STAT+: Trump administration demands pharma companies begin drug price negotiations, a day after key deadline
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
WASHINGTON \u2014 The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in line with what other countries pay \u2014 usually far less than Americans.<\/p>\n
\u201cUnder President Trump\u2019s direction, HHS is demanding that pharmaceutical companies end their obstruction and come to the table\u2014just as they already do with nearly every other economically comparable nation\u2014to negotiate fair, transparent pricing for Americans,\u201d an agency spokesperson said in a statement to STAT, adding that the companies were \u201cprevent[ing] progress of lowering prices for the American people.\u201d<\/p>\n
The spokesperson did not immediately clarify how companies were preventing that progress. The administration\u2019s statement comes after pharmaceutical executives said they were expecting more details about the kinds of drugs that would be up for negotiations and the price targets for them.\u00a0<\/p>\n
Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n